Diagnostic challenges in distinguishing pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm from mass-forming pancreatitis: A case report
This case report highlights the diagnostic challenge of distinguishing pancreatic ductal adenocarcinoma concomitant with occult intraductal papillary mucinous neoplasm from mass-forming pancreatitis, emphasizing that atypical diffuse high-density imaging and negative preoperative biopsies can lead to misdiagnosis, necessitating comprehensive postoperative pathological evaluation to guide long-term management.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The pancreas is a small, vital organ tucked behind the stomach, acting as both a factory for digestive enzymes and a control center for blood sugar. When this organ develops a tumor, the most common and dangerous type is a cancer that starts in the tubes carrying digestive juices, known as pancreatic ductal adenocarcinoma. Doctors often rely on medical scans to spot these tumors, looking for dark, shadowy spots where the tissue has died or changed. However, the human body is rarely simple. Sometimes, a different kind of growth, a precancerous condition called an intraductal papillary mucinous neoplasm, hides alongside the cancer. This second condition involves the buildup of thick, jelly-like fluid inside the ducts. The challenge for doctors is that these two conditions can appear together, yet the scans used to find them often miss the second one entirely, leading to a situation where a patient might be treated for one problem while a hidden threat remains.
This story begins with a sixty-three-year-old man who arrived at the hospital with a yellowing of his skin and eyes, a sign that his bile duct was blocked. He felt no pain, but the blockage was causing his bilirubin levels to rise significantly. When doctors scanned his abdomen, they saw something confusing. Instead of the usual dark, shadowy mass that typically signals pancreatic cancer, the head of his pancreas appeared uniformly bright and dense. The main tubes carrying bile and digestive juices were both swollen, a pattern doctors call the "double duct sign," which usually points to a blockage. Because the tissue looked so dense and uniform, and because there was no clear lump or cyst visible on the images, the medical team initially suspected a rare form of inflammation called mass-forming pancreatitis. Even a closer look with an ultrasound probe and a needle biopsy failed to find the cancer or the hidden precancerous growth. The needle only found some inflammatory cells and a few strange-looking cells, but nothing definitive.
Faced with a blockage that could not be explained by simple inflammation and a risk that cancer was hiding in plain sight, the doctors decided to operate. During the surgery, the tissue in the head of the pancreas felt hard and stiff, with no clear boundary separating it from the healthy organ. The surgeons took small samples of this hard tissue to examine under a microscope while the patient was still on the operating table. The results came back quickly: the hard tissue was indeed cancer. The surgeons proceeded to remove the head of the pancreas, a major operation known as a pancreaticoduodenectomy. As they opened the organ, they found the main duct filled with a gelatinous mucus, but they saw no obvious cysts or papillary growths that would typically signal the presence of the precancerous condition. The rest of the pancreas, the body and tail, looked normal, so the surgeons left them in place to preserve the patient's ability to digest food and regulate blood sugar.
The true surprise came only after the surgery was finished and the removed tissue was studied in great detail by a pathologist. While the main diagnosis was confirmed as pancreatic cancer, the pathologist also found a second, separate condition hidden within the same piece of tissue. There was a precancerous growth, a main-duct type intraductal papillary mucinous neoplasm, located just a few millimeters away from where the cancer was. This growth was low to intermediate in its severity, meaning it had the potential to become cancerous over time, but it had not yet done so. Crucially, this second condition had been completely invisible before the surgery. It did not show up on the CT scans, the MRI, or the ultrasound. It did not have the cysts or nodules that usually give it away. The two conditions existed side by side in the same organ, yet the imaging tools had only seen the cancer, and even then, only because the cancer looked like inflammation rather than a typical tumor.
This case highlights a difficult reality in medical diagnosis: the absence of evidence is not always evidence of absence. The cancer in this patient did not look like the textbook version of the disease; it was dense and infiltrative, mimicking inflammation so closely that it fooled the initial scans. At the same time, the precancerous growth was so subtle and lacked the typical features that it remained a secret until the organ was removed. The doctors had to make a decision about how much of the pancreas to remove. Removing the entire organ would have eliminated the risk of the hidden growth turning into cancer later, but it would have left the patient with severe, lifelong health issues. Instead, the team chose to leave the rest of the pancreas intact but established a strict plan to monitor the remaining tissue with regular scans every six months.
The lesson from this patient's journey is that when the pancreas head appears abnormally dense on a scan, especially when accompanied by swollen ducts, doctors must remain alert to the possibility of hidden conditions. The cancer might not look like a dark spot, and a precancerous growth might not look like a cyst. The only way to be certain is through a thorough examination of the tissue after surgery. For this patient, the surgery was successful, and at six months of follow-up, there were no signs of the cancer returning or the hidden growth getting worse. He has recovered well, though he will need to keep a close watch on his remaining pancreas for the rest of his life. This case serves as a reminder that even with advanced technology, the human body can keep its secrets until the very end, requiring doctors to look beyond what the machines show and rely on careful, detailed analysis to ensure nothing is missed.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.